000			01891 a2200565 4500
005			20250515150456.0
264		0	_c20090429
008			200904s 0 0 eng d
022			_a0920-9964
024	7		_a10.1016/j.schres.2008.10.011 _2doi
040			_aNLM _beng _cNLM
100	1		_aStroup, T Scott
245	0	0	_aResults of phase 3 of the CATIE schizophrenia trial. _h[electronic resource]
260			_bSchizophrenia research _cJan 2009
300			_a1-12 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntipsychotic Agents _xtherapeutic use
650	0	4	_aAripiprazole
650	0	4	_aBenzodiazepines _xtherapeutic use
650	0	4	_aChronic Disease
650	0	4	_aClozapine _xtherapeutic use
650	0	4	_aDibenzothiazepines _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHospitalization _xstatistics & numerical data
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOlanzapine
650	0	4	_aPerphenazine _xtherapeutic use
650	0	4	_aPiperazines _xtherapeutic use
650	0	4	_aQuetiapine Fumarate
650	0	4	_aQuinolones _xtherapeutic use
650	0	4	_aRisperidone _xtherapeutic use
650	0	4	_aSchizophrenia _xdrug therapy
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aLieberman, Jeffrey A
700	1		_aMcEvoy, Joseph P
700	1		_aDavis, Sonia M
700	1		_aSwartz, Marvin S
700	1		_aKeefe, Richard S E
700	1		_aMiller, Alexander L
700	1		_aRosenheck, Robert A
700	1		_aHsiao, John K
773	0		_tSchizophrenia research _gvol. 107 _gno. 1 _gp. 1-12
856	4	0	_uhttps://doi.org/10.1016/j.schres.2008.10.011 _zAvailable from publisher's website
999			_c18483518 _d18483518